Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 16, 2022 (4 years ago)

Draximage MAA

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2.5 mg per vial, 30 glass vials per carton, Rx Only, Manufactured for Jubilant Draximage Inc. Kirkland, Canada, NDC 65174-270-30.

Affected NDC 65174-0270-30

Compare with the code on your package — it is the most precise check available.

Drug: Albumin

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Draximage Maa
Kit for the preparation of Technetium Tc 99m Albumin aggregated
NDC 65174-0270
ALBUMIN AGGREGATED 2.5 mg/1 Injection, Powder, for Solution
Intravenous
Jubilant DraxImage Inc Rx
Recalling firm
Jubilant Draximage Inc
NDC code
65174-270-30
Origin
Canada
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1189-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Albumin recalls

See all
Class II · Moderate risk

C-*Albumin Eye Drop 10% S

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 44206-0251-05 D-1073-2020

Other recalls by Jubilant Draximage Inc

All 2022 recalls